• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Protein Therapeutics Market Size

    ID: MRFR/LS/8664-HCR
    200 Pages
    Rahul Gotadki
    October 2025

    Protein Therapeutics Market Research Report By Type (Monoclonal Antibodies, Recombinant Proteins, Hormones, Vaccines), By Application (Oncology, Autoimmune Diseases, Infectious Diseases, Metabolic Disorders), By End Use (Hospital, Research Laboratories, Pharmaceutical Companies), By Mode of Administration (Intravenous, Subcutaneous, Intramuscular) and By Regional (North America, Europe, South A...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Protein Therapeutics Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Protein Therapeutics Size

    Protein Therapeutics Market Growth Projections and Opportunities

    Protein treatments are affected by the rising frequency of chronic diseases including cancer, diabetes, and autoimmune disorders. Protein-based medications, which assist treat chronic conditions, are in demand as these diseases proliferate worldwide. Biotechnology advances affect the protein therapies business. Innovative approaches for protein expression, purification, and modification boost therapeutic protein output and efficacy, driving market expansion. Older adults have more chronic diseases that protein therapies can treat, making them a key market segment. Protein therapies can cure these illnesses. Protein-based medicines that are efficacious and personalized are in demand as the world's population ages. Pharmaceutical and biotechnology companies' research and development activities boost the Protein Therapeutics market. Significant investments in innovative therapeutic protein discovery and formulation enhancement affect innovation and market competitiveness. Government policies and regulations heavily impact the protein therapies sector. Research and development initiatives fuel market growth, and strict regulations ensure protein-based therapies are safe and effective. The emergence of protein therapy biopharmaceutical companies has brought a dynamic new aspect to the market. These companies develop new treatments and specialize in certain areas, making the protein therapeutics industry diverse and competitive. Patients' demand for biologics, including protein-based medications, drives market dynamics. As biologics become more desirable due to their focused processes and lower side effects, protein treatments are becoming more popular. Technical platforms and manufacturing processes that have improved greatly help define the protein therapies industry. Improved protein synthesis, purification, and formulation methods increase scalability and cost-effectiveness, which expands potential markets. Economic variables affect protein therapy availability and cost globally and regionally. Economic stability and healthcare costs affect market expansion and protein-based medication adoption. Competitive landscape, defined by prominent pharmaceutical manufacturing businesses, affects market dynamics. The Protein Therapeutics market may be altered by major industry players via mergers, acquisitions, and product launches, increasing competition and innovation.

    Protein Therapeutics Market Size Graph

    Market Summary

    As per Market Research Future Analysis, the Protein Therapeutics Market was valued at 222.58 USD Billion in 2024 and is projected to grow to 464.67 USD Billion by 2035, with a CAGR of 6.92% from 2025 to 2035. The market is driven by the rising incidence of chronic diseases and an aging population, alongside advancements in biotechnology and regulatory support.

    Key Market Trends & Highlights

    The Protein Therapeutics Market is experiencing transformative trends driven by healthcare demands and technological advancements.

    • Monoclonal Antibodies are expected to dominate the market, valued at 95.0 USD Billion in 2024, growing to 180.0 USD Billion by 2035. Recombinant Proteins are projected to reach 70.0 USD Billion in 2024 and 130.0 USD Billion by 2035. The global aging population is expected to double from 1 billion in 2020 to 2.1 billion by 2050, increasing demand for protein therapeutics. Investment in biotechnology surpassed USD 80 billion in 2021, reflecting a trend towards innovative drug development.

    Market Size & Forecast

    2024 Market Size USD 222.58 Billion
    2035 Market Size USD 464.67 Billion
    CAGR (2025-2035) 6.92%
    Largest Regional Market Share in 2024 North America

    Major Players

    <p>Genentech, Pfizer, Roche, AbbVie, Eli Lilly, Johnson and Johnson, Gilead Sciences, Biogen, Novartis, Regeneron Pharmaceuticals, Celgene, Bristol Myers Squibb, Merck, Amgen, Sanofi</p>

    Market Trends

    The Protein Therapeutics Market is undergoing change due to a number of prominent trends. One area of growth is the chronic disease patients due to the high demand for effective treatments. The development of innovative and targeted biopharmaceuticals has broadened the treatment options available for cancer, diabetes, and other autoimmune diseases. Moreover, the global shift towards personalized medicine is transforming how treatments are designed and administered and is increasing the requirement for proteins tailored to specific patient needs.

    Possibilities exist in the increasing focus on biosimilars, which are perceived to be more favorable in cost compared to already existing biologics, as they are gaining traction in many markets around the globe. Increased attention towards sustainable production and the emergence of green chemistry in the manufacturing processes of protein therapeutics presents other possibilities.

    Furthermore, these technologies are applied in therapy processes, which helps in more accurate assessment of patient treatment responses and makes it possible to change treatment modalities more quickly. The very existence of this environment illustrates the ever-changing aspects of the Protein Therapeutics Market and its response to modern needs.

     

    <p>The Global Protein Therapeutics Market is poised for robust growth, driven by advancements in biopharmaceutical technologies and an increasing demand for targeted therapies.</p>

    U.S. Food and Drug Administration (FDA)

    Protein Therapeutics Market Market Drivers

    Advancements in Biotechnology

    Technological advancements in biotechnology are propelling the Global Protein Therapeutics Market Industry forward. Innovations in genetic engineering, protein design, and production techniques are enhancing the development of novel therapeutics. For instance, the advent of CRISPR technology allows for precise modifications in protein structures, leading to more effective treatments. This progress is expected to contribute to a compound annual growth rate of 5.9% from 2025 to 2035. As biotechnology continues to evolve, it is likely that new protein-based therapies will emerge, further expanding the market and addressing unmet medical needs.

    Market Trends and Projections

    Rising Prevalence of Chronic Diseases

    The Global Protein Therapeutics Market Industry is experiencing growth due to the increasing prevalence of chronic diseases such as diabetes, cancer, and autoimmune disorders. As of 2024, the market is valued at approximately 239.6 USD Billion, driven by the need for innovative treatment options. Protein therapeutics, including monoclonal antibodies and recombinant proteins, are becoming essential in managing these conditions. The demand for targeted therapies is likely to rise, as they offer improved efficacy and reduced side effects compared to traditional treatments. This trend suggests a robust future for the industry, potentially reaching 450 USD Billion by 2035.

    Growing Demand for Personalized Medicine

    The shift towards personalized medicine is significantly influencing the Global Protein Therapeutics Market Industry. Patients increasingly seek treatments tailored to their genetic profiles, which enhances therapeutic efficacy and minimizes adverse effects. This trend is evident in the rising approval rates of biologics that target specific patient populations. As the market evolves, the demand for protein therapeutics that align with personalized treatment approaches is expected to grow. This could potentially drive the market to reach 450 USD Billion by 2035, as healthcare systems adapt to more individualized care models.

    Increasing Investment in Research and Development

    Investment in research and development is a critical driver for the Global Protein Therapeutics Market Industry. Pharmaceutical companies are allocating substantial resources to discover and develop new protein therapeutics. In 2024, the market is projected to be valued at 239.6 USD Billion, reflecting the industry's commitment to innovation. Governments and private entities are also funding initiatives aimed at accelerating the development of biologics. This influx of capital is likely to enhance the pipeline of protein therapeutics, ultimately leading to a more diverse range of treatment options for patients and contributing to market growth.

    Regulatory Support and Streamlined Approval Processes

    Regulatory support is fostering growth in the Global Protein Therapeutics Market Industry. Regulatory agencies are implementing streamlined approval processes for biologics, which facilitates faster market entry for new protein therapeutics. This support is crucial in addressing the urgent need for innovative treatments in various therapeutic areas. As the market continues to expand, the anticipated compound annual growth rate of 5.9% from 2025 to 2035 underscores the positive impact of regulatory frameworks. The collaborative efforts between industry stakeholders and regulatory bodies are likely to enhance the development and availability of protein therapeutics.

    Market Segment Insights

    Protein Therapeutics Market Type Insights

    <p>The Protein Therapeutics Market, a pivotal segment within the biopharmaceutical industry, encompasses a range of products that play a crucial role in disease management and treatment. In 2024, this market was valued at 239.63 USD Billion, with the Type segment significantly contributing to these figures. Among the various types, Monoclonal Antibodies are set to dominate the market, with a valuation of 95.0 USD Billion in 2024 and expected growth to 180.0 USD Billion by 2035.</p>

    <p>This category not only represents majority holding within the market but also reflects their fundamental role in targeted therapies for cancers, autoimmune diseases, and infectious diseases, which are becoming increasingly prevalent globally.</p>

    <p>Recombinant Proteins are also substantial in the Protein Therapeutics Market and are expected to be valued at 70.0 USD Billion in 2024, scaling to 130.0 USD Billion by 2035. These proteins, crucial for therapies involving enzymes and hormones, demonstrate a robust demand due to advancements in biotechnology and increasing chronic disease prevalence.</p>

    Protein Therapeutics Market Application Insights

    <p>The Protein Therapeutics Market is projected to achieve a valuation of 239.63 USD Billion in 2024, highlighting its substantial growth potential across various applications. This market is primarily driven by the increasing prevalence of chronic diseases and advancements in biotechnology. Within this landscape, the application scope encompasses critical areas such as Oncology, Autoimmune Diseases, Infectious Diseases, and Metabolic Disorders. Oncology stands out as a significant segment due to the rising rates of cancer globally, fostering innovation in targeted therapies.</p>

    <p>Similarly, the management of Autoimmune Diseases has gained momentum as awareness and diagnostic capabilities improve, leading to more effective treatment modalities. Infectious Diseases continue to be a major challenge, with protein therapeutics offering novel solutions to combat emerging pathogens. Lastly, Metabolic Disorders, which affect millions globally, benefit from protein-based interventions that enhance treatment efficacy.</p>

    <p>As these segments evolve, they highlight the Protein Therapeutics Market segmentation's critical role in addressing urgent healthcare needs and driving innovation in therapeutic strategies.Overall, the market reflects ongoing trends in healthcare technology advancements and an increasing focus on personalized medicine solutions.</p>

    Protein Therapeutics Market End Use Insights

    <p>The Protein Therapeutics Market is extensively categorized based on End Use, primarily comprising hospitals, research laboratories, and pharmaceutical companies. As of 2024, the market achieved a valuation of approximately 239.63 USD Billion. Hospitals are crucial users of protein therapeutics, facilitating patient care through advanced treatment options, thus playing a significant role in the demand for these therapies.</p>

    <p>Research laboratories contribute by conducting essential studies that lead to innovative therapeutic solutions, making their role in the Protein Therapeutics Market industry vital for ongoing development and discovery.Pharmaceutical companies dominate the landscape, taking the lead in the development and commercialization of protein-based drugs, thus driving the overall market growth. The integration of biopharmaceutical advancements and increasing healthcare expenditures contribute positively to the growth of this segment, highlighting the significant opportunities within the Protein Therapeutics Market.</p>

    <p>Market statistics suggest that ongoing research and development in protein therapeutics are essential for addressing unmet medical needs, thus reinforcing the importance of these End Use categories in the global scenario.</p>

    Protein Therapeutics Market Mode of Administration Insights

    <p>The Protein Therapeutics Market is seeing a notable shift in its Mode of Administration segment, which includes options such as Intravenous, Subcutaneous, and Intramuscular delivery methods. In 2024, the overall market reached a value of 239.63 USD Billion, reflecting the growing demand for protein-based therapies globally. Intravenous administration remains a dominant mode due to its rapid onset of action and is often preferred in hospital settings, particularly for patients requiring immediate therapeutic effects. Subcutaneous administration is gaining traction as it allows for self-administration, enhancing patient compliance and convenience.</p>

    <p>Intramuscular injections are also significant in this segment, favored for their versatility and ease of administration. The increasing prevalence of chronic diseases, advancements in drug formulations, and a growing focus on personalized medicine are driving the growth of these administration methods. Additionally, the expansion of healthcare infrastructure in emerging economies further elevates the Protein Therapeutics Market revenue, paving the way for innovative delivery mechanisms to cater to diverse patient needs. The market is expected to exhibit substantial growth, as strategies evolve to optimize delivery efficiency and patient experience across these administration modes.</p>

    Get more detailed insights about Protein Therapeutics Market Research Report - Forecast till 2035

    Regional Insights

    The Protein Therapeutics Market exhibits significant regional variations, with North America dominating the landscape, valued at 110.0 USD Billion in 2024 and projected to reach 210.0 USD Billion by 2035. This robust growth is primarily driven by advanced healthcare infrastructure, substantial investments in Research and Development, and a high prevalence of chronic diseases in the region. Europe follows closely, with a valuation of 70.0 USD Billion in 2024, expected to grow to 120.0 USD Billion by 2035. The European market benefits from a strong regulatory framework and increasing collaborations between industry and academia.

    The Asia-Pacific (APAC) region is valued at 45.0 USD Billion in 2024, with the potential to double to 90.0 USD Billion by 2035, showcasing rapid advancements in biotechnology and a rising demand for affordable healthcare solutions. South America, while smaller, is valued at 10.0 USD Billion in 2024 and is anticipated to reach 20.0 USD Billion by 2035, largely driven by increasing investments in healthcare services. The Middle East and Africa (MEA) market, valued at 4.63 USD Billion in 2024 and 10.0 USD Billion by 2035, remains the smallest segment, reflecting ongoing challenges in healthcare access and infrastructure.

    Overall, each region holds unique characteristics that contribute to the growing Protein Therapeutics Market revenue, indicating diverse opportunities and challenges across the globe.

    Protein Therapeutics Market Region

    Key Players and Competitive Insights

    The competitive landscape of the Protein Therapeutics Market is characterized by extensive innovation and a rapidly evolving environment. As the demand for targeted therapies and biologics continues to rise, companies are investing significantly in research and development to enhance their product portfolios. The market dynamics exhibit a blend of established pharmaceutical giants alongside emerging biotechnology firms, each striving to gain a competitive edge through strategic partnerships, advanced technologies, and a focus on patient-centric solutions.

    The competition is further intensified by the increasing prevalence of chronic diseases and the need for effective treatment options, leading to a heightened emphasis on developing novel protein-based therapeutics that can address unmet medical needs.

    Genentech has established itself as a formidable player in the Protein Therapeutics Market, leveraging its robust pipeline and a commitment to research excellence. The company's strengths lie in its extensive portfolio of monoclonal antibodies and proprietary drug delivery technologies, enabling it to offer innovative treatments across various therapeutic areas such as oncology and immunology. Genentech's research-driven approach, combined with strong collaborations with healthcare professionals and patients, enhances its market presence.

    The company's investment in cutting-edge technologies and a focus on personalized medicine positions it effectively to respond to market demands and maintain leadership within the competitive landscape.Pfizer has likewise made significant contributions to the Protein Therapeutics Market through its diverse array of biopharmaceutical products and its strong global footprint. The company offers key protein-based therapeutics in various therapeutic areas, including oncology, rare diseases, and infectious diseases.

    Pfizer's strengths stem from its extensive research capabilities, a global distribution network, and strategic mergers and acquisitions that have broadened its product offerings and market reach. By integrating innovative technologies and maintaining a commitment to public health, Pfizer is adept at adapting to changing market dynamics. The combination of established products, ongoing clinical trials, and an expansive pipeline promotes Pfizer's competitiveness on a global scale.

    Additionally, the company's agile approach to leveraging collaborations helps it to continuously evolve in response to the emerging needs of the protein therapeutics landscape.

    Key Companies in the Protein Therapeutics Market market include

    Industry Developments

    Recent developments in the Protein Therapeutics Market have shown significant activities among major players such as Genentech, Pfizer, and AbbVie. In September 2023, AbbVie announced advancements in clinical trials for its new protein therapies aimed at treating rare diseases, reflecting a robust focus on Research and Development. Meanwhile, in August 2023, Roche secured regulatory approval for a breakthrough treatment that promises to improve patient outcomes in oncology.

    Mergers and acquisitions continue to shape the market; for example, in July 2023, Pfizer completed its acquisition of a biotech firm specializing in innovative protein-based drugs, enhancing its product pipeline. The market saw a valuation increase, driven by the success of monoclonal antibodies and protein-based therapies in addressing various conditions including autoimmune diseases and cancers.

    Overall, these developments highlight the dynamic landscape of the Protein Therapeutics Market, underscored by ongoing investments and regulatory progress that are poised to impact future growth trajectories for key companies like Johnson and Johnson, Gilead Sciences, and Bristol Myers Squibb. Significant movements within this sector are indicative of the increasing demand for effective therapeutic solutions on a global scale.

    Future Outlook

    Protein Therapeutics Market Future Outlook

    <p>The Protein Therapeutics Market is projected to grow at a 6.92% CAGR from 2025 to 2035, driven by advancements in biologics, increasing prevalence of chronic diseases, and rising demand for personalized medicine.</p>

    New opportunities lie in:

    • <p>Invest in biomanufacturing technologies to enhance production efficiency and reduce costs. Develop novel protein-based therapies targeting rare diseases for niche market penetration. Leverage AI and machine learning for drug discovery and development processes.</p>

    <p>By 2035, the Protein Therapeutics Market is expected to achieve substantial growth, reflecting a robust and dynamic landscape.</p>

    Market Segmentation

    Protein Therapeutics Market Type Outlook

    • Monoclonal Antibodies
    • Recombinant Proteins
    • Hormones
    • Vaccines

    Protein Therapeutics Market End Use Outlook

    • Hospital
    • Research Laboratories
    • Pharmaceutical Companies

    Protein Therapeutics Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Protein Therapeutics Market Application Outlook

    • Oncology
    • Autoimmune Diseases
    • Infectious Diseases
    • Metabolic Disorders

    Protein Therapeutics Market Mode of Administration Outlook

    • Intravenous
    • Subcutaneous
    • Intramuscular

    Report Scope

    Report Attribute/Metric Source:Details
    MARKET SIZE 2024222.58(USD Billion)
    MARKET SIZE 2035464.67(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)6.92% (2025 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    MARKET FORECAST PERIOD2025 - 2035
    HISTORICAL DATA2019 - 2024
    MARKET FORECAST UNITSUSD Billion
    KEY COMPANIES PROFILEDGenentech, Pfizer, Roche, AbbVie, Eli Lilly, Johnson and Johnson, Gilead Sciences, Biogen, Novartis, Regeneron Pharmaceuticals, Celgene, BristolMyers Squibb, Merck, Amgen, Sanofi
    SEGMENTS COVEREDType, Application, End Use, Mode of Administration, Regional
    KEY MARKET OPPORTUNITIESIncreasing chronic disease prevalence, Expanding biologics integration, Advancements in personalized medicine, Growth in biosimilars market, Rising demand for innovative therapies.
    KEY MARKET DYNAMICSRising demand for biologics, Advancements in drug development, Increasing prevalence of chronic diseases, Growth in personalized medicine, Expanding applications of monoclonal antibodies
    COUNTRIES COVEREDNorth America, Europe, APAC, South America, MEA
    Market Size 2024222.58
    Market Size 2025237.99
    Market Size 2035464.67
    Base Year2024
    Market Forecast Period2025 - 2035

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    What is the projected growth of the Protein Therapeutics market?

    The Protein Therapeutics market is the expected increase in total market value of 464.67 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Protein Therapeutics market?

    Protein Therapeutics market size was valued at approximately 222.58 billion USD in 2024. This figure will reach 464.67 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Protein Therapeutics market?

    Protein Therapeutics market is expected to grow at a CAGR of 6.92% between 2025 and 2035.

    How much will the Protein Therapeutics market be worth by 2035?

    Protein Therapeutics market is expected to be worth of 464.67 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Protein Therapeutics market perform over the next 10 years?

    Over the next 10 years the Protein Therapeutics market is expected to shift from usd billion 222.58 to 464.67 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    Which region is anticipated to hold the largest market share in the Global Protein Therapeutics Market by 2035?

    North America is anticipated to hold the largest market share in the Global Protein Therapeutics Market, projected to be valued at 210.0 USD Billion by 2035.

    What are the projected market values for Monoclonal Antibodies from 2024 to 2035?

    The projected market value for Monoclonal Antibodies is expected to increase from 95.0 USD Billion in 2024 to 180.0 USD Billion in 2035.

    Who are the key players in the Global Protein Therapeutics Market?

    Key players in the Global Protein Therapeutics Market include Genentech, Pfizer, Roche, AbbVie, Eli Lilly, and Johnson &amp; Johnson.

    What is the anticipated market size for Recombinant Proteins in 2024?

    The anticipated market size for Recombinant Proteins in 2024 is estimated to be 70.0 USD Billion.

    What is the projected market value for Vaccines by 2035?

    The projected market value for Vaccines is expected to reach 90.0 USD Billion by 2035.

    1. Table of Contents
    2. EXECUTIVE SUMMARY
    3. Market Overview
    4. Key Findings
    5. Market Segmentation
    6. Competitive Landscape
    7. Challenges and Opportunities
    8. Future Outlook
    9. MARKET INTRODUCTION
    10. Definition
    11. Scope of the study
    12. Research Objective
    13. Assumption
    14. Limitations
    15. RESEARCH METHODOLOGY
    16. Overview
    17. Data Mining
    18. Secondary Research
    19. Primary Research
    20. Primary Interviews and Information Gathering Process
    21. Breakdown of Primary Respondents
    22. Forecasting Model
    23. Market Size Estimation
    24. Bottom-Up Approach
    25. Top-Down Approach
    26. Data Triangulation
    27. Validation
    28. MARKET DYNAMICS
    29. Overview
    30. Drivers
    31. Restraints
    32. Opportunities
    33. MARKET FACTOR ANALYSIS
    34. Value chain Analysis
    35. Porter's Five Forces Analysis
    36. Bargaining Power of Suppliers
    37. Bargaining Power of Buyers
    38. Threat of New Entrants
    39. Threat of Substitutes
    40. Intensity of Rivalry
    41. COVID-19 Impact Analysis
    42. Market Impact Analysis
    43. Regional Impact
    44. Opportunity and Threat Analysis
    45. Protein Therapeutics Market, BY Type (USD Billion)
    46. Monoclonal Antibodies
    47. Recombinant Proteins
    48. Hormones
    49. Vaccines
    50. Protein Therapeutics Market, BY Application (USD Billion)
    51. Oncology
    52. Autoimmune Diseases
    53. Infectious Diseases
    54. Metabolic Disorders
    55. Protein Therapeutics Market, BY End Use (USD Billion)
    56. Hospital
    57. Research Laboratories
    58. Pharmaceutical Companies
    59. Protein Therapeutics Market, BY Mode of Administration (USD Billion)
    60. Intravenous
    61. Subcutaneous
    62. Intramuscular
    63. Protein Therapeutics Market, BY Regional (USD Billion)
    64. North America
    65. US
    66. Canada
    67. Europe
    68. Germany
    69. UK
    70. France
    71. Russia
    72. Italy
    73. Spain
    74. Rest of Europe
    75. APAC
    76. China
    77. India
    78. Japan
    79. South Korea
    80. Malaysia
    81. Thailand
    82. Indonesia
    83. Rest of APAC
    84. South America
    85. Brazil
    86. Mexico
    87. Argentina
    88. Rest of South America
    89. MEA
    90. GCC Countries
    91. South Africa
    92. Rest of MEA
    93. Competitive Landscape
    94. Overview
    95. Competitive Analysis
    96. Market share Analysis
    97. Major Growth Strategy in the Protein Therapeutics Market
    98. Competitive Benchmarking
    99. Leading Players in Terms of Number of Developments in the Protein Therapeutics Market
    100. Key developments and growth strategies
    101. New Product Launch/Service Deployment
    102. Merger & Acquisitions
    103. Joint Ventures
    104. Major Players Financial Matrix
    105. Sales and Operating Income
    106. Major Players R&D Expenditure. 2023
    107. Company Profiles
    108. Genentech
    109. Financial Overview
    110. Products Offered
    111. Key Developments
    112. SWOT Analysis
    113. Key Strategies
    114. Pfizer
    115. Financial Overview
    116. Products Offered
    117. Key Developments
    118. SWOT Analysis
    119. Key Strategies
    120. Roche
    121. Financial Overview
    122. Products Offered
    123. Key Developments
    124. SWOT Analysis
    125. Key Strategies
    126. AbbVie
    127. Financial Overview
    128. Products Offered
    129. Key Developments
    130. SWOT Analysis
    131. Key Strategies
    132. Eli Lilly
    133. Financial Overview
    134. Products Offered
    135. Key Developments
    136. SWOT Analysis
    137. Key Strategies
    138. Johnson and Johnson
    139. Financial Overview
    140. Products Offered
    141. Key Developments
    142. SWOT Analysis
    143. Key Strategies
    144. Gilead Sciences
    145. Financial Overview
    146. Products Offered
    147. Key Developments
    148. SWOT Analysis
    149. Key Strategies
    150. Biogen
    151. Financial Overview
    152. Products Offered
    153. Key Developments
    154. SWOT Analysis
    155. Key Strategies
    156. Novartis
    157. Financial Overview
    158. Products Offered
    159. Key Developments
    160. SWOT Analysis
    161. Key Strategies
    162. Regeneron Pharmaceuticals
    163. Financial Overview
    164. Products Offered
    165. Key Developments
    166. SWOT Analysis
    167. Key Strategies
    168. Celgene
    169. Financial Overview
    170. Products Offered
    171. Key Developments
    172. SWOT Analysis
    173. Key Strategies
    174. BristolMyers Squibb
    175. Financial Overview
    176. Products Offered
    177. Key Developments
    178. SWOT Analysis
    179. Key Strategies
    180. Merck
    181. Financial Overview
    182. Products Offered
    183. Key Developments
    184. SWOT Analysis
    185. Key Strategies
    186. Amgen
    187. Financial Overview
    188. Products Offered
    189. Key Developments
    190. SWOT Analysis
    191. Key Strategies
    192. Sanofi
    193. Financial Overview
    194. Products Offered
    195. Key Developments
    196. SWOT Analysis
    197. Key Strategies
    198. Appendix
    199. References
    200. Related Reports

    Protein Therapeutics Market Segmentation

    Protein Therapeutics Market By Type (USD Billion, 2019-2035)

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    Protein Therapeutics Market By Application (USD Billion, 2019-2035)

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    Protein Therapeutics Market By End Use (USD Billion, 2019-2035)

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    Protein Therapeutics Market By Mode of Administration (USD Billion, 2019-2035)

    Intravenous

    Subcutaneous

    Intramuscular

    Protein Therapeutics Market By Regional (USD Billion, 2019-2035)

    North America

    Europe

    South America

    Asia Pacific

    Middle East and Africa

    Protein Therapeutics Market Regional Outlook (USD Billion, 2019-2035)

    North America Outlook (USD Billion, 2019-2035)

    North America Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    North America Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    North America Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    North America Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    North America Protein Therapeutics Market by Regional Type

    US

    Canada

    US Outlook (USD Billion, 2019-2035)

    US Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    US Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    US Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    US Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    CANADA Outlook (USD Billion, 2019-2035)

    CANADA Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    CANADA Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    CANADA Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    CANADA Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    Europe Outlook (USD Billion, 2019-2035)

    Europe Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    Europe Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    Europe Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    Europe Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    Europe Protein Therapeutics Market by Regional Type

    Germany

    UK

    France

    Russia

    Italy

    Spain

    Rest of Europe

    GERMANY Outlook (USD Billion, 2019-2035)

    GERMANY Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    GERMANY Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    GERMANY Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    GERMANY Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    UK Outlook (USD Billion, 2019-2035)

    UK Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    UK Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    UK Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    UK Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    FRANCE Outlook (USD Billion, 2019-2035)

    FRANCE Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    FRANCE Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    FRANCE Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    FRANCE Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    RUSSIA Outlook (USD Billion, 2019-2035)

    RUSSIA Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    RUSSIA Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    RUSSIA Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    RUSSIA Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    ITALY Outlook (USD Billion, 2019-2035)

    ITALY Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    ITALY Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    ITALY Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    ITALY Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    SPAIN Outlook (USD Billion, 2019-2035)

    SPAIN Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    SPAIN Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    SPAIN Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    SPAIN Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    REST OF EUROPE Outlook (USD Billion, 2019-2035)

    REST OF EUROPE Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    REST OF EUROPE Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    REST OF EUROPE Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    REST OF EUROPE Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    APAC Outlook (USD Billion, 2019-2035)

    APAC Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    APAC Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    APAC Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    APAC Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    APAC Protein Therapeutics Market by Regional Type

    China

    India

    Japan

    South Korea

    Malaysia

    Thailand

    Indonesia

    Rest of APAC

    CHINA Outlook (USD Billion, 2019-2035)

    CHINA Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    CHINA Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    CHINA Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    CHINA Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    INDIA Outlook (USD Billion, 2019-2035)

    INDIA Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    INDIA Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    INDIA Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    INDIA Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    JAPAN Outlook (USD Billion, 2019-2035)

    JAPAN Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    JAPAN Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    JAPAN Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    JAPAN Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    SOUTH KOREA Outlook (USD Billion, 2019-2035)

    SOUTH KOREA Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    SOUTH KOREA Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    SOUTH KOREA Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    SOUTH KOREA Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    MALAYSIA Outlook (USD Billion, 2019-2035)

    MALAYSIA Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    MALAYSIA Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    MALAYSIA Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    MALAYSIA Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    THAILAND Outlook (USD Billion, 2019-2035)

    THAILAND Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    THAILAND Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    THAILAND Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    THAILAND Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    INDONESIA Outlook (USD Billion, 2019-2035)

    INDONESIA Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    INDONESIA Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    INDONESIA Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    INDONESIA Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    REST OF APAC Outlook (USD Billion, 2019-2035)

    REST OF APAC Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    REST OF APAC Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    REST OF APAC Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    REST OF APAC Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    South America Outlook (USD Billion, 2019-2035)

    South America Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    South America Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    South America Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    South America Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    South America Protein Therapeutics Market by Regional Type

    Brazil

    Mexico

    Argentina

    Rest of South America

    BRAZIL Outlook (USD Billion, 2019-2035)

    BRAZIL Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    BRAZIL Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    BRAZIL Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    BRAZIL Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    MEXICO Outlook (USD Billion, 2019-2035)

    MEXICO Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    MEXICO Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    MEXICO Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    MEXICO Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    ARGENTINA Outlook (USD Billion, 2019-2035)

    ARGENTINA Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    ARGENTINA Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    ARGENTINA Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    ARGENTINA Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)

    REST OF SOUTH AMERICA Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    REST OF SOUTH AMERICA Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    REST OF SOUTH AMERICA Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    REST OF SOUTH AMERICA Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    MEA Outlook (USD Billion, 2019-2035)

    MEA Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    MEA Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    MEA Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    MEA Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    MEA Protein Therapeutics Market by Regional Type

    GCC Countries

    South Africa

    Rest of MEA

    GCC COUNTRIES Outlook (USD Billion, 2019-2035)

    GCC COUNTRIES Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    GCC COUNTRIES Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    GCC COUNTRIES Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    GCC COUNTRIES Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    SOUTH AFRICA Outlook (USD Billion, 2019-2035)

    SOUTH AFRICA Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    SOUTH AFRICA Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    SOUTH AFRICA Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    SOUTH AFRICA Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    REST OF MEA Outlook (USD Billion, 2019-2035)

    REST OF MEA Protein Therapeutics Market by Type

    Monoclonal Antibodies

    Recombinant Proteins

    Hormones

    Vaccines

    REST OF MEA Protein Therapeutics Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Metabolic Disorders

    REST OF MEA Protein Therapeutics Market by End Use Type

    Hospital

    Research Laboratories

    Pharmaceutical Companies

    REST OF MEA Protein Therapeutics Market by Mode of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

     

     

    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027